GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

71

KRAS + MTAP Loss Defines a Poor-Risk Pancreatic Cancer Subgroup: Clinical Cancer Research | June 2026

This study highlights the importance of comprehensive genomic profiling in pancreatic adenocarcinoma, not only for identifying targetable alterations but also for defining biologically distinct prognostic subgroups. The analysis...

72

BREAKWATER Cohort 3: New First-Line Standard for BRAF V600E Metastatic Colorectal Cancer: Annals of Oncology | May 2026

BRAF V600E-mutant metastatic colorectal cancer represents one of the most aggressive molecular subtypes of colorectal cancer, accounting for approximately 8%–12% of cases and historically associated with poor outcomes....

73

EOCRC Treatment Delays: Language Barriers Are a Modifiable Risk Factor: JAMA Oncology | June 2026

Early age–onset colorectal cancer is increasing globally and is now a major public health concern, especially because many patients present before routine screening age. This population-based Texas Cancer...

74

PRISM Study: Real-World Outcomes of First-Line Systemic Therapy for Unresectable HCC: Liver Cancer | May 2026

PRISM is one of the largest prospective real-world studies evaluating systemic therapy for unresectable hepatocellular carcinoma in routine clinical practice across Japan. This analysis reports outcomes from the...

75

DUPAN-2 Enables Biomarker Monitoring in CA19-9 Nonexpressors : JAMA Surg | Jun 2026

Introduction: Introduction: Carbohydrate antigen 19-9 (CA19-9) is the most widely used serum biomarker in pancreatic ductal adenocarcinoma (PDAC), guiding treatment response assessment, prognostication, and postoperative surveillance. However, approximately...

76

Quorum-Sensing Signals Drive Colitis-Associated Cancer in UC : Gastroenterology | June 2026

Introduction: Ulcerative Colitis is associated with an increased long-term risk of Colitis-Associated Cancer, particularly in patients with prolonged inflammatory disease activity. Although microbiome dysbiosis is increasingly implicated in...

77

ESD Outperforms TEM for Early Rectal Tumors : Gastroenterology | June 2026

Introduction: Early Rectal Cancer and advanced rectal adenomas are increasingly managed with organ-preserving local excision strategies. Endoscopic Submucosal Dissection and Transanal Endoscopic Microsurgery are the two principal approaches...

78

AI-Assisted Endoscopy Reduces Blind Spots, Not Missed Gastric Neoplasia : Gastroenterology | June 2026

Introduction: Gastric Cancer remains a major global cause of cancer mortality, particularly in East Asia, where early detection through upper gastrointestinal endoscopy is central to improving outcomes. Artificial...

79

F. prausnitzii–PIA Axis Suppresses CRC Progression : Gastroenterology | June 2026

Introduction: Colorectal Cancer is increasingly recognized as a disease strongly influenced by host–microbiome metabolic interactions. Although gut microbial dysbiosis has been linked to colorectal carcinogenesis, the mechanistic interplay...

80

Zanidatamab Redefines First-Line HER2+ GEA Therapy : NEJM | May 2026

Introduction Gastroesophageal Adenocarcinoma remains an aggressive malignancy with limited long-term survival despite HER2-directed therapy. Since the ToGA era, trastuzumab-based chemotherapy has remained the standard first-line treatment, but therapeutic...

Previous
178920
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer